Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lars M. H. Reinders"'
Autor:
Lars M. H. Reinders, Martin D. Klassen, Thorsten Teutenberg, Martin Jaeger, Torsten C. Schmidt
Publikováno v:
Analytical and Bioanalytical Chemistry. 414:6761-6769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5568907a70ffb5d9cc0b6a5e642b83
https://doi.org/10.1007/s00216-022-04236-8
https://doi.org/10.1007/s00216-022-04236-8
Publikováno v:
Advances in biochemical engineering/biotechnology. 182
In order to ensure a high level of product quality and safety, regular quality controls are mandatory, especially in the pharmaceutical industry. These quality controls are strictly regulated and require a high level of documentation. With the goal o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e48cb6a876ce76d9c66e27eb09cf859
https://pubmed.ncbi.nlm.nih.gov/35091813
https://pubmed.ncbi.nlm.nih.gov/35091813
Publikováno v:
Smart Biolabs of the Future ISBN: 9783031125812
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b6c8717bf5cd918b09ec8ecc451720
https://doi.org/10.1007/10_2021_190
https://doi.org/10.1007/10_2021_190
Autor:
Lars M H, Reinders, Martin D, Klassen, Thorsten, Teutenberg, Martin, Jaeger, Torsten C, Schmidt
Publikováno v:
Analytical and bioanalytical chemistry. 414(23)
Due to the complex manufacturing process of therapeutic monoclonal antibodies, it is hardly possible to produce an identical copy of the original product (originator). Consequently, follow-on products (biosimilars) must demonstrate their efficacy bei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::311915cc70aec7a2da9a097486032601
https://pubmed.ncbi.nlm.nih.gov/35895102
https://pubmed.ncbi.nlm.nih.gov/35895102
Autor:
Jochen Tuerk, Lars M H Reinders, Thorsten Teutenberg, Martin Jaeger, Claudia vom Eyser, Martin D Klassen, Torsten C. Schmidt
The drugs used for treatment during chemotherapy are manufactured individually for each patient in specialised pharmacies. Thorough quality control to confirm the identity of the delivered active pharmaceutical ingredient and the final concentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d080f5f5c1348c747172206f7d9d28e
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85101391386
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85101391386
Complete characterization and quantification of monoclonal antibodies often rely on enzymatic digestion with trypsin. In order to accelerate and automate this frequently performed sample preparation step, immobilized enzyme reactors (IMER) compatible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a336e4397c0414893fcf42ba023c201
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85116746809
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85116746809
Monoclonal antibodies are a group of commonly used therapeutics, whose occupational health risk is still discussed controversially. The long-term low-dose exposure side effects are insufficiently evaluated; hence, discussions are often based on a the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950132440da54a23e99a9b1c32210bfa
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85044966723
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85044966723